Good morning.
How are you going to have a weekend? When we are resting, the world is still surging. The new week begins, and watch the world with Tiger Sniff~
New Alzheimer’s disease drug approved for marketing, will be put into production
@IT之家[Green Valley Pharmaceuticals Chairman: Anti-Al The independent research and development of innovative drugs for Alzheimer’s disease will be put into operation on November 7th] On November 2nd, the State Food and Drug Administration issued a document indicating that it has conditionally approved the application for the registration of mannite sodium capsules for mild to medium Alzheimer’s disease (commonly known as Alzheimer’s disease), this drug is an innovative drug independently researched and developed by China.
On November 3, Lu Songtao, chairman of Green Valley Pharmaceuticals, said that the anti-Alzheimer’s disease drug Gunlut sodium capsule (GV-971) will be put into operation on November 7 and will be put before December 29th. Drugs spread across the country. In addition, 40 acres of land will be provided for industrialization in Pudong New Area of Shanghai. Construction will start within this year. If construction can be completed in three years, it can satisfy the sales of 2 million patients.
Image Source: Screenshot of the National Drug Administration website
At the same time, everyone’s concern about whether Alzheimer’s new drugs can enter the medical insurance policy has also received a response: